Evidence map›Paper›PMID 38742477›Full record

SynthesisJournal of cachexia, sarcopenia and muscle2024

Skeletal muscle hypertrophy rewires glucose metabolism: An experimental investigation and systematic review.

Philipp Baumert, Sakari Mäntyselkä, Martin Schönfelder, Marie Heiber, Mika Jos Jacobs, Anandini Swaminathan, Petras Minderis, Mantas Dirmontas, Karin Kleigrewe, Chen Meng and 7 more

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of cachexia, sarcopenia and muscle, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Cancer cachexia: molecular basis and therapeutic advances.Signal transduction and targeted therapy · 2026
    Review
  11. Maximal lactate accumulation rate (European journal of applied physiology · 2026
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Philipp BaumertSchool of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID 0000-0002-5463-1954
Sakari MäntyselkäFaculty of Sport and Health Sciences, NeuroMuscular Research Center, University of Jyväskylä, Jyväskylä, Finland.
Martin SchönfelderSchool of Medicine and Health, Technical University of Munich, Munich, Germany.
Marie HeiberSchool of Medicine and Health, Technical University of Munich, Munich, Germany.
Mika Jos JacobsSchool of Medicine and Health, Technical University of Munich, Munich, Germany.
Anandini SwaminathanInstitute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania.
Petras MinderisInstitute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania.
Mantas DirmontasDepartment of Health Promotion and Rehabilitation, Lithuanian Sports University, Kaunas, Lithuania.
Karin KleigreweBavarian Center for Biomolecular Mass Spectrometry, Technical University of Munich, Munich, Germany.
Chen MengBavarian Center for Biomolecular Mass Spectrometry, Technical University of Munich, Munich, Germany.
Michael GiglBavarian Center for Biomolecular Mass Spectrometry, Technical University of Munich, Munich, Germany.
Ildus I AhmetovResearch Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.
Tomas VenckunasInstitute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania.
Hans DegensInstitute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania.
Aivaras RatkeviciusInstitute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania.
Juha J HulmiFaculty of Sport and Health Sciences, NeuroMuscular Research Center, University of Jyväskylä, Jyväskylä, Finland.
Henning WackerhageSchool of Medicine and Health, Technical University of Munich, Munich, Germany.

Funding

Company of Biologists Travelling FellowshipDeutsche Diabetes StiftungEuropean Commission 754462TUM University Foundation FellowshipUniversity of Jyväskylä (JYU) Visiting Fellow Program
6 · The paper itself

Abstract

backgroundProliferating cancer cells shift their metabolism towards glycolysis, even in the presence of oxygen, to especially generate glycolytic intermediates as substrates for anabolic reactions. We hypothesize that a similar metabolic remodelling occurs during skeletal muscle hypertrophy.

methodsWe used mass spectrometry in hypertrophying C2C12 myotubes in vitro and plantaris mouse muscle in vivo and assessed metabolomic changes and the incorporation of the [U-

resultsThe metabolomics analysis in myotubes revealed insulin-like growth factor-1 (IGF-1)-induced altered metabolite concentrations in anabolic pathways such as pentose phosphate (ribose-5-phosphate/ribulose-5-phosphate: +40%; P = 0.01) and serine synthesis pathway (serine: -36.8%; P = 0.009). Like the hypertrophy stimulation with IGF-1 in myotubes in vitro, the concentration of the dipeptide l-carnosine was decreased by 26.6% (P = 0.001) during skeletal muscle growth in vivo. However, phosphorylated sugar (glucose-6-phosphate, fructose-6-phosphate or glucose-1-phosphate) decreased by 32.2% (P = 0.004) in the overloaded muscle in vivo while increasing in the IGF-1-stimulated myotubes in vitro. The systematic review revealed that 10 metabolites linked to muscle hypertrophy were directly associated with glycolysis and its interconnected anabolic pathways. We demonstrated that labelled carbon from [U-

conclusionsUnderstanding the mechanisms that regulate skeletal muscle mass will help in developing effective treatments for muscle weakness. Our results provide evidence for the metabolic rewiring of glycolytic intermediates into anabolic pathways during muscle growth, such as in serine synthesis.

Indexed as

GlucoseMuscle, SkeletalAnimalsHumansHypertrophyInsulin-Like Growth Factor IMetabolomicsMiceMuscle Fibers, SkeletalGlucoseInsulin-Like Growth Factor Ilactatemetabolomicsresistance exerciseserine synthesis pathwayWarburg effect

Identifiers

PMID38742477
PMCPMC11154753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.